Evidence map›Paper›PMID 33767265›Full record

ArticleScientific reports2021

Degradation of insulin amyloid by antibiotic minocycline and formation of toxic intermediates.

Wakako Mori, Keisuke Yuzu, Nadine Lobsiger, Hideo Nishioka, Hisako Sato, Terumasa Nagase, Keiichi Iwaya, Mikael Lindgren, Tamotsu Zako

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Wakako MoriDepartment of Chemistry and Biology, Graduate School of Science and Engineering, Ehime University, Ehime, 790-8577, Japan.
Keisuke YuzuDepartment of Chemistry and Biology, Graduate School of Science and Engineering, Ehime University, Ehime, 790-8577, Japan.
Nadine LobsigerDepartment of Chemistry and Biology, Graduate School of Science and Engineering, Ehime University, Ehime, 790-8577, Japan.
Hideo NishiokaApplication Management Department, JEOL Ltd, Tokyo, 196-8558, Japan.
Hisako SatoDepartment of Chemistry and Biology, Graduate School of Science and Engineering, Ehime University, Ehime, 790-8577, Japan.
Terumasa NagaseDepartment of Metabolism and Endocrinology, Tokyo Medical University Ibaraki Medical Center, Ibaraki, 3000395, Japan.
Keiichi IwayaDepartment of Pathology, SASAKI Institute, Kyoundo Hospital, Tokyo, 101-0062, Japan.
Mikael LindgrenDepartment of Physics, Faculty of Natural Sciences, Norwegian University of Science and Technology, 7491, Trondheim, Norway.
Tamotsu ZakoDepartment of Chemistry and Biology, Graduate School of Science and Engineering, Ehime University, Ehime, 790-8577, Japan. zako.tamotsu.us@ehime-u.ac.jp.
Ehime University · JPJEOL (Japan) · JPNorwegian University of Science and Technology · NOSasaki Institute · JPTokyo Medical University Ibaraki Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Insulin balls, localized insulin amyloids formed at subcutaneous insulin-injection sites in patients with diabetes, cause poor glycemic control owing to impairments in insulin absorption. Our previous study has shown that some insulin balls are cytotoxic, but others are not, implying amyloid polymorphism. Interestingly, the patient with toxic insulin balls had been treated with antibiotic minocycline, suggesting a possible relationship between toxicity of insulin balls and minocycline. However, the direct effect of minocycline on the structure and cytotoxicity of the insulin amyloid is still unclear. Herein, we demonstrated that that minocycline at physiological concentrations induced degradation of insulin amyloids formed from human insulin and insulin drug preparations used for diabetes patients. Interestingly, the process involved the initial appearance of the toxic species, which subsequently changed into less-toxic species. It is also shown that the structure of the toxic species was similar to that of sonicated fragments of human insulin amyloids. Our study shed new light on the clarification of the revelation of insulin balls and the development of the insulin analogs for diabetes therapy.

Indexed as

AmyloidAmyloidosisAnti-Bacterial AgentsHeLa CellsHumansInsulinMinocyclineAmyloidAnti-Bacterial AgentsInsulinMinocycline

Identifiers

PMID33767265
PMCPMC7994847
OpenAlexW3138629491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.